ArticleVaccines2025

Safety and Cross-Neutralizing Immunity Against SARS-CoV-2 Omicron Sub-Variant After a Booster Dose with SOBERANA

Dagmar García-Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.